Bleakley Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,280
| Closed | -$317K | – | 656 |
|
|
2024
Q4 | $317K | Sell |
4,280
-241
| -5% | -$17.8K | 0.01% | 782 |
|
|
2024
Q3 | $298K | Sell |
4,521
-2,131
| -32% | -$141K | 0.01% | 780 |
|
|
2024
Q2 | $614K | Sell |
6,652
-77
| -1% | -$7.11K | 0.02% | 540 |
|
|
2024
Q1 | $643K | Sell |
6,729
-8,424
| -56% | -$805K | 0.02% | 543 |
|
|
2023
Q4 | $1.16M | Buy |
15,153
+3,296
| +28% | +$251K | 0.04% | 369 |
|
|
2023
Q3 | $821K | Sell |
11,857
-1,939
| -14% | -$134K | 0.03% | 416 |
|
|
2023
Q2 | $1.3M | Buy |
13,796
+5,029
| +57% | +$474K | 0.04% | 350 |
|
|
2023
Q1 | $725K | Buy |
8,767
+1,078
| +14% | +$89.2K | 0.02% | 473 |
|
|
2022
Q4 | $574K | Buy |
+7,689
| New | +$574K | 0.02% | 515 |
|